Aclaris Therapeutics
Manufacturing · Pennsylvania, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
701 Lee Rd Ste 103, Chesterbrook, Pennsy...Phone Number
(484) 324-7933Website
www.aclaristx.comRevenue
$8.2 MillionStock Symbol
ACRSIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Aclaris Therapeutics
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation.Explore more
Aclaris Therapeutics Org Chart
b2/20220119085815okyddzEyf6.png)
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aclaris Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Aclaris Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Aclaris Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Aclaris Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Aclaris Therapeutics
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Aclaris Therapeutics has new funding data
Product Launch: Get notified when Aclaris Therapeutics launches new products
Earning: See what the market has to say on Aclaris Therapeutics recently announced quarterly report
Check if Aclaris Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Aclaris Therapeutics
Find more new buyers
Compare Similar Companies to Aclaris Therapeutics
Compare insights from companies similar to Aclaris Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Aclaris Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Aclaris Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Aclaris Therapeutics.
Aclaris Therapeutics financials insights
Gather financial insights about Aclaris Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Series A
$21M
2014
Series B
$21M
2015
Series C
$40M
Stock Offering
$56.5M
2016
Share Placement
$20M
2020
Debt
$11M
Aclaris Therapeutics Tech Stack
A closer look at the technologies used by Aclaris Therapeutics
Most Recent Scoops
Open Position
Earnings
Earnings, Finance
Earnings
Earnings, Finance
Person-Based
Earnings, Business Finance, Clinical Operations, Finance
Project
Pharmaceuticals
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aclaris Therapeutics
Sign Up For FreeTo access detailed company insights
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulat... Read More
